More News

31 Mar 2007 Astellas Licenses RegeneronĀ“s Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
31 Mar 2007 Takeda to Obtain Development and Commercial Rights
31 Mar 2007 CanBas and Takeda to Sign the Collaboration Agreement
31 Mar 2007 LG Life Sciences and Takeda Announce Collaboration
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
30 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
30 Mar 2007 Ad hoc: Evotec to Acquire Neuro3d
29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
29 Mar 2007 Wockhardt receives US FDA approval for anti-inflammatory injection
29 Mar 2007 Wockhardt receives US FDA approval for diuretic injection, Second FDA approval in a week
29 Mar 2007 Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
28 Mar 2007 Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
28 Mar 2007 Taro Receives Tentative Approval for Ciclopirox Topical Solution, 8% (Nail Lacquer) ANDA
28 Mar 2007 BrainCells Inc. and Lundbeck Form CNS Drug Research Collaboration
28 Mar 2007 Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
27 Mar 2007 Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
27 Mar 2007 Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
27 Mar 2007 Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
24 Mar 2007 NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
23 Mar 2007 Topigen and Novagali enter into strategic collaboration for allergic ocular diseases and allergic rhinitis
23 Mar 2007 Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
23 Mar 2007 Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
23 Mar 2007 MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
23 Mar 2007 VASTox plc Acquires DanioLabs Ltd and Dextra Laboratories Ltd to Strengthen Its Drug Discovery Pipeline and Pharmaceutical Services Business

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top